Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add filters








Year range
1.
The Journal of Practical Medicine ; (24): 2105-2108, 2016.
Article in Chinese | WPRIM | ID: wpr-495648

ABSTRACT

Objective To explore the characteristics and biological functions of epigenetic treatment to DNMT1 expression in NSCLC cell lines. Methods Lung cancer cells were divided into 4 groups , and drugs with different concentrations. The effect of epigenetic treatment on NSCLC cell line was detected by CCK-8 and MTT. The effect of epigenetic treatment on the expression of DNMT1 in NSCLC cell line was detected by Western blot. Results CCK-8 and MTT assay showed that treatment with 5-Aza-CdR and MS-275 inhibited the proliferation of NSCLC cells. Western blot showed that treatment with 5-Aza-CdR and MS-275 inhibited the DNMT1 expression in NSCLC cells. Conclusion The expression of DNMT1 gene in the NSCLC cell lines may be suppressed effectively by epigenetic treatment , and the gene may inhibit the proliferation and growth of NSCLC cell lines.

2.
Chinese Journal of Endemiology ; (12): 96-98, 2014.
Article in Chinese | WPRIM | ID: wpr-444132

ABSTRACT

Objective To analyze the clinical feature of thalassemia with pulmonary hypertension and investigate the influence of pulmonary hypertension on thalassemia.Methods From June 2007 to July 2011,clinical data of 19 patients with thalassemia complicated with pulmonary hypertension in TEDA International Cardiovascular Hospital of Tianjin Medical University and Affilated Hospital of Guilin Medical College were analyzed retrospectively.Twenty-two cases of thalassemia without pulmonary hypertension were as a control group,and follow-up time was set as 4 months to 24 months.Observed indicators included age,hemoglobin(Hb),lactate dehydrogenase (LDH),serum ferritin (SF),tricuspid regurgitation velocity (TRV) and left ventricular ejection fraction (LVEF).Results SF and TRV of the case group[(693.6 ± 234.6)μg/L and (2.6 ± 0.1)m/s] were significantly higher than those of the control [(209.5 ± 100.1) μg/L and (2.1 ± 0.3)m/s,all P < 0.05]; but the differences between case and control group in Hb[(90.8 ± 10.7)g/L vs (89.3 ± 10.5)g/L],LDH[(320.9 ± 103.7)U/L vs (355.8 ± 140.3)U/L] and LVEF[(66.2 ± 7.1)% vs (64.2 ± 4.7)%] were not statistically significant (all P > 0.05).Logrank analysis showed that the prognosis was poor in patients with thalassemia complicated with pulmonary hypertension (x2 =4.95,P < 0.05).Multiple regression analysis indicated that age and serum ferritin remained as predisposing risk factors for tricuspid regurgitation velocity,and serum ferritin had a greater impact on the velocity.Conclusion In patients with thalassemia complicated with pulmonary hypertension,the prognosis is poor; age and SF may be factors involved in the development of pulmonary hypertension.

3.
Chinese Journal of Clinical Oncology ; (24): 1570-1572, 2013.
Article in Chinese | WPRIM | ID: wpr-439760

ABSTRACT

The five-year survival rate of lung cancer, one of the cancers with higher morbidity and death rate, is less than 15%. Studies have shown that the occurrence of lung cancer is related to many factors in which epigenetics is an important one. In recent years, with the successful clinical application of epigenetic therapy drugs such as methylation transferase and histone deacetylase inhibi-tors that can enhance the sensitivity of chemotherapy, epigenetics has become a research hotspot. This paper briefly introduces the re-search progress in DNA methylation, acetylation, and cancer chemotherapy sensitivity in lung cancer diagnosis and treatment.

4.
Pakistan Journal of Medical Sciences. 2012; 28 (4): 732-734
in English | IMEMR | ID: emr-132271

ABSTRACT

We describe a 22-year-old Chinese woman with a history of cough and hemoptysis due to an unusual giant mediastinal mass with pulmonary involvement. The tumor was successfully resected via a left lateral thoracotomy and a median sternotomy. The histopathological diagnosis was a mature mediastinal teratoma. We describe here the management of this case and wish to emphasise that the surgical resection is feasible in giant mediastinal mature teratoma

5.
Chinese Journal of Tissue Engineering Research ; (53): 9544-9548, 2011.
Article in Chinese | WPRIM | ID: wpr-423918

ABSTRACT

BACKGROUND: Our former studies have shown that bone marrow mesenchymal stem cells (BMMSCs) can be induced differentiation to vascular smooth muscle-like cells (VSMLCs) and vascular endothelium-like cells (VELCs), which are compatible with collagen-embedded polyglycolic acid scaffolds. OBJECTIVE: To investigate the possibility of constructing small diameter tissue-engineered blood vessels via subcutaneous implantation. METHODS: The cells-scaffold complex was produced by separately seeding VSMLCs and VELCs derived from BMMSCs on polyglycolic acid collagen scaffolds. The two layers were separated by ECMgel. The cells-scaffold complex was subcutaneous implanted into small diameter tissue-engineered blood vessels.RESULTS AND CONCLUSION: Histological analysis of the small diameter tissue-engineered blood vessel walls revealed a typical artery structure, which was similar to natural vessels. The tissue-engineered blood vessels were not broken down under a force of 26.6 kPa. Eight weeks after implantation, the Brdu-labeled seed cells were found in the three layers of the vessel walls. The results revealed that the subcutaneous tissue was a good bioreactor to construct small diameter tissue-engineered blood vessels.

SELECTION OF CITATIONS
SEARCH DETAIL